The global Nucleic Acid Electrophoresis and Blotting market size is predicted to grow from US$ 3149 million in 2025 to US$ 5629 million in 2031; it is expected to grow at a CAGR of 10.2% from 2025 to 2031.
Electrophoresis is a technique used to separate DNA, RNA, and proteins using an electrical current based on the molecular weight or fragment size. The electrophoresis reagents being used in the electrophoresis technique are known as electrophoresis reagents. This technology is widely used in the fields of medical diagnostics and life sciences and clinical research.
Life science reagents are the fundamental materials for life science research and development, and are widely used as consumable tools in life science research activities. According to Frost&Sullivan"s data, the global market size of biological reagents has reached US $12.8 billion in 2015 and US $17.5 billion in 2019, with a Compound annual growth rate of 8.1%.
LPI (LP Information)' newest research report, the “Nucleic Acid Electrophoresis and Blotting Industry Forecast” looks at past sales and reviews total world Nucleic Acid Electrophoresis and Blotting sales in 2024, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Electrophoresis and Blotting sales for 2025 through 2031. With Nucleic Acid Electrophoresis and Blotting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Electrophoresis and Blotting industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid Electrophoresis and Blotting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acid Electrophoresis and Blotting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Electrophoresis and Blotting market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Electrophoresis and Blotting and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Electrophoresis and Blotting.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Electrophoresis and Blotting market by product type, application, key players and key regions and countries.
Segmentation by Type:
Nucleic Acid Electrophoresis Reagents
Nucleic Acid Electrophoresis Apparatus
Software
Others
Segmentation by Application:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Forensic Laboratories
Hospitals and Diagnostics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad
Agilent Technologies
BioAtlas
Cytiva
Lonza Group
Merck KGaA
Qiagen
Takara Bio
Thermo Fisher Scientific
Promega Corporation
Hoefer
Sebia Group
Randox Laboratories
Helena Laboratories Corporation
ELITechGroup
LabRepCo
Abcam
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook